Tampere University of Technology

TUTCRIS Research Portal

Photodynamic therapy of malignant brain tumours: A complementary approach to conventional therapies

Research output: Contribution to journalReview ArticleScientificpeer-review

Details

Original languageEnglish
Pages (from-to)229-241
Number of pages13
JournalCANCER TREATMENT REVIEWS
Volume40
Issue number2
DOIs
Publication statusPublished - Mar 2014
Publication typeA2 Review article in a scientific journal

Abstract

The poor outcome of primary malignant brain tumours is predominantly due to local invasion and local recurrence and their prognosis is highly dependent on the degree of resection. They have no border and, at best, a marginal zone that remains invisible to the surgeon. Photodynamic therapy (PDT) appears to be an interesting modality to fill the need for a targeted treatment that may reduce recurrence and extend survival with minimal side effects.In this review, we summarize the different technologies of brain tumour PDT employed such as interstitial PDT, and PDT-associated surgical resection, describing new light delivery devices. The role of dosimetry - one of the key factors behind successful brain tumour PDT - is discussed. This can be achieved by integrating results from in vivo studies. In this context, the development of new therapeutic photosensitizer delivery systems is also an area of significant research interest. Multifunctionality can be engineered into a single nanoplatform to provide tumour-specific detection, treatment, and follow-up. Such multitasking systems appear to be complementary to conventional technologies.

Keywords

  • Brain tumors, Clinical, Fluorescence-guided resection, Interventional MRI, Nanoparticles, Photodynamic therapy, Pre-clinical